Non-Current Liabilities
Deferred Tax Liabilities - Foreign Earnings
Merck & Co. Deferred Tax Liabilities - Foreign Earnings decreased by 8.9% to $338.00M in Q4 2025 compared to the prior quarter. Over 2 years (FY 2023 to FY 2025), Deferred Tax Liabilities - Foreign Earnings shows an upward trend with a 69.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryRisk
SignalLower is better
VolatilityStable
First reportedQ4 2014
Last reportedQ4 2025Feb 24, 2026
How to read this metric
An increase suggests a growing reliance on foreign earnings or a shift in repatriation strategy, while a decrease may indicate tax planning changes or actual repatriation.
Detailed definition
This metric quantifies the deferred tax liability recognized on the undistributed earnings of foreign subsidiaries that...
Peer comparison
Standard for multinational corporations; levels depend on the geographic footprint and local tax laws of the firm.
Metric ID:
deferred_tax_liabilities_foreign_earningsHistorical Data
3 periods
| Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|
| Value | $118.00M | $371.00M | $338.00M |
| QoQ Change | — | +214.4% | -8.9% |
| YoY Change | — | +214.4% | -8.9% |
Range$118.00M – $371.00M
Avg YoY Growth+102.8%
Median YoY Growth+102.8%
Deferred Tax Liabilities - Foreign Earnings at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s deferred tax liabilities - foreign earnings?
- Merck & Co. (MRK) reported deferred tax liabilities - foreign earnings of $338.00M in Q4 2025.
- What is the long-term trend for Merck & Co.'s deferred tax liabilities - foreign earnings?
- Over 2 years (2023 to 2025), Merck & Co.'s deferred tax liabilities - foreign earnings has grown at a 69.2% compound annual growth rate (CAGR), from $118.00M to $338.00M.
- What does deferred tax liabilities - foreign earnings mean?
- The estimated tax cost of bringing foreign profits back to the home country.